Drugmaker Vivus settles with biggest shareholder
Friday, July 19, 2013 - 08:00
in Mathematics & Economics
(AP)—Obesity drugmaker Vivus has agreed to a settlement with its biggest shareholder, which has been fighting for greater control of the company. A long-time drug executive backed by the shareholder will become CEO and the board will be reconfigured.